228 related articles for article (PubMed ID: 35887910)
1. Effect of the Crohn's Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn's Disease.
Matuszczyk M; Meglicka M; Wiernicka A; Jarzębicka D; Osiecki M; Kotkowicz-Szczur M; Kierkuś J
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887910
[TBL] [Abstract][Full Text] [Related]
2. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
[TBL] [Abstract][Full Text] [Related]
3. Formula modifications to the Crohn's disease exclusion diet do not impact therapy success in paediatric Crohn's disease.
Landorf E; Hammond P; Abu-Assi R; Ellison S; Boyle T; Comerford A; Couper R
J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1279-1286. PubMed ID: 38623960
[TBL] [Abstract][Full Text] [Related]
4. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.
Yanai H; Levine A; Hirsch A; Boneh RS; Kopylov U; Eran HB; Cohen NA; Ron Y; Goren I; Leibovitzh H; Wardi J; Zittan E; Ziv-Baran T; Abramas L; Fliss-Isakov N; Raykhel B; Gik TP; Dotan I; Maharshak N
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):49-59. PubMed ID: 34739863
[TBL] [Abstract][Full Text] [Related]
5. Oral exclusive enteral nutrition for induction of clinical remission, mucosal healing, and improvement of nutritional status and growth velocity in children with active Crohn's disease - a prospective multicentre trial.
Matuszczyk M; Meglicka M; Landowski P; Czkwianianc E; Sordyl B; Szymańska E; Kierkuś J
Prz Gastroenterol; 2021; 16(4):346-351. PubMed ID: 34976243
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Crohn's disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review.
Jijón Andrade MC; Pujol Muncunill G; Lozano Ruf A; Álvarez Carnero L; Vila Miravet V; García Arenas D; Egea Castillo N; Martín de Carpi J
BMC Gastroenterol; 2023 Jun; 23(1):225. PubMed ID: 37386458
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
Zhou S; Huang Z; Hou W; Lin Y; Yu J
Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.
Lee D; Baldassano RN; Otley AR; Albenberg L; Griffiths AM; Compher C; Chen EZ; Li H; Gilroy E; Nessel L; Grant A; Chehoud C; Bushman FD; Wu GD; Lewis JD
Inflamm Bowel Dis; 2015 Aug; 21(8):1786-93. PubMed ID: 25970545
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Active Crohn's Disease in Children Using Partial Enteral Nutrition Combined with a Modified Crohn's Disease Exclusion Diet: A Pilot Prospective Cohort Trial on Clinical and Endoscopic Outcomes.
Urlep D; Orel R; Kunstek P; Benedik E
Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960328
[TBL] [Abstract][Full Text] [Related]
10. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
[TBL] [Abstract][Full Text] [Related]
11. Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study.
Verburgt CM; Dunn KA; Otley A; Heyman MB; Verstraete S; Sunseri W; Sylvester F; de Meij T; Comeau A; Langille M; de Jonge WJ; Benninga MA; Van Limbergen JE
BMJ Open; 2023 Feb; 13(2):e064944. PubMed ID: 36725090
[TBL] [Abstract][Full Text] [Related]
12. Is There Evidence of Crohn's Disease Exclusion Diet (CDED) in Remission of Active Disease in Children and Adults? A Systematic Review.
Correia I; Oliveira PA; Antunes ML; Raimundo MDG; Moreira AC
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613020
[TBL] [Abstract][Full Text] [Related]
13. Sustained Diet-Induced Remission in Pediatric Crohn's Disease Is Associated With Kynurenine and Serotonin Pathways.
Ghiboub M; Boneh RS; Sovran B; Wine E; Lefèvre A; Emond P; Verburgt CM; Benninga MA; de Jonge WJ; Van Limbergen JE
Inflamm Bowel Dis; 2023 May; 29(5):684-694. PubMed ID: 36637175
[TBL] [Abstract][Full Text] [Related]
14. Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.
Ghiboub M; Penny S; Verburgt CM; Boneh RS; Wine E; Cohen A; Dunn KA; Pinto DM; Benninga MA; de Jonge WJ; Levine A; Van Limbergen JE
Gastroenterology; 2022 Oct; 163(4):922-936.e15. PubMed ID: 35679949
[TBL] [Abstract][Full Text] [Related]
15. Modified Crohn's disease exclusion diet is equally effective as exclusive enteral nutrition: Real-world data.
Niseteo T; Sila S; Trivić I; Mišak Z; Kolaček S; Hojsak I
Nutr Clin Pract; 2022 Apr; 37(2):435-441. PubMed ID: 34339527
[TBL] [Abstract][Full Text] [Related]
16. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn's disease under infliximab therapy.
Cao WT; Huang R; Liu S; Fan YH; Xu MS; Xu Y; Ni H
World J Gastroenterol; 2022 Jun; 28(23):2582-2596. PubMed ID: 35949356
[TBL] [Abstract][Full Text] [Related]
17. Crohn's disease exclusion diet in children with Crohn's disease: a case series.
Scarallo L; Banci E; Pierattini V; Lionetti P
Curr Med Res Opin; 2021 Jul; 37(7):1115-1120. PubMed ID: 33951997
[TBL] [Abstract][Full Text] [Related]
18. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn's disease.
Somwaru AS; Khanijow V; Katabathina VS
BMC Gastroenterol; 2019 Dec; 19(1):210. PubMed ID: 31805875
[TBL] [Abstract][Full Text] [Related]
20. Role of adjuvant Crohn's disease exclusion diet plus enteral nutrition in asymptomatic pediatric Crohn's disease having biochemical activity: A randomized, pilot study.
Arcucci MS; Menendez L; Orsi M; Gallo J; Guzman L; Busoni V; Lifschitz C
Indian J Gastroenterol; 2024 Feb; 43(1):199-207. PubMed ID: 37610564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
